Search

everythinglearnresearchcommunity

for

Search:↓

Oral JAK inhibitors improved alopecia areata by modulating immune responses and boosting hair growth.

Upadacitinib effectively improved severe atopic dermatitis and alopecia universalis in a 29-year-old man.

Telitacicept effectively improved hair regrowth in a woman with lupus and alopecia.

SIG-1451 could be a promising new treatment for atopic dermatitis.

A humanized CXCL12 antibody may delay and treat alopecia areata by altering the immune response.

A humanized IL-2 fusion protein boosts T regulatory cells and helps control hair loss in Alopecia Areata.

Dupilumab can both heal and cause hair loss.

A medication for skin rash also unexpectedly treated hair loss in a patient.

Ritlecitinib is effective and safe for treating severe alopecia areata in people aged 12 and older.

The document did not conclude on apremilast's effectiveness for severe alopecia areata.

A rare skin condition linked to leukemia improved with chemotherapy.

Biologics, especially Dupilumab, are effective and safe for treating severe childhood eczema.

Apremilast may help treat hair loss in alopecia areata.

Topical squaric acid dibutylester worsened discoid lupus erythematosus in a patient.

Tildrakizumab showed limited effectiveness in treating chronic alopecia areata in a small group of patients.

A mutation in the IL2RA gene increases the risk of alopecia areata.

Dexamethasone oral mini-pulse therapy effectively treats severe alopecia areata when JAK inhibitors can't be used.

Nab-paclitaxel chemotherapy can rarely cause lupus-like skin issues.

ALEP is a drug-triggered skin reaction with pustules that clears up in a week after stopping the drug.

Fresh plasma transfusions did not help treat Leiner disease in an infant.

Ustekinumab significantly improved psoriasis, vitiligo, and alopecia areata in a patient.

Deuruxolitinib effectively improves hair regrowth in alopecia areata but requires monitoring for side effects.

A man got six skin cancers within a year after a cell transplant for leukemia but was cancer-free 32 months later; skin checks are important post-transplant.

Dual-targeting therapies like Janus kinase inhibitors may treat both alopecia areata and other immune diseases.

The drug showed promise in treating renal cell carcinoma with manageable side effects.

Dupilumab effectively reduces alopecia areata symptoms in children with atopic dermatitis.

Azathioprine can cause severe hair loss and low white blood cell count in lupus patients.